Twelve bio Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Employees
-
2
- Latest Deal Type
-
M&A
- Investors
-
1
Twelve bio General Information
Description
Developer of a CRISPR diagnostic technology designed to detect early-stage lung cancer. The company's diagnostic test can identify lung cancer from a blood test and a gene-editing toolbox to target a wide range of genetic disorders and provide tailored and safe molecules, thereby enabling patients to reduce both time and expense to get treatment for incurable diseases.
Contact Information
Website
www.twelve.bioCorporate Office
- BII Ole Maaloes Vej 3
- 2200 Copenhagen
- Denmark
Corporate Office
- BII Ole Maaloes Vej 3
- 2200 Copenhagen
- Denmark
Twelve bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 05-Jan-2023 | Completed | Generating Revenue | |||
| 6. Seed Round | 09-Mar-2021 | Completed | Startup | |||
| 5. Seed Round | 01-Oct-2020 | Completed | Startup | |||
| 4. Accelerator/Incubator | 22-Sep-2020 | Completed | Startup | |||
| 3. Grant | 19-Nov-2019 | Completed | Startup | |||
| 2. Accelerator/Incubator | 25-Oct-2019 | $36.9K | $36.9K | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2019 | Completed | Startup |
Twelve bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 17,144 | $105.9 | $105.9 | 1x | $105.9 | 16.96% |
Twelve bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Twelve bio Patents
Twelve bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023131870-A3 | Cas12a endonculease variants and methods of use | Inactive | 06-Jan-2022 | ||
| WO-2023131870-A2 | Endonuclease variants and methods of use | Inactive | 06-Jan-2022 |
Twelve bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Twelve bio Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arix Bioscience | Venture Capital | Minority | ||
| BioInnovation Institute | Accelerator/Incubator | |||
| Novo Holdings | Venture Capital | Minority |
Twelve bio FAQs
-
When was Twelve bio founded?
Twelve bio was founded in 2019.
-
Where is Twelve bio headquartered?
Twelve bio is headquartered in Copenhagen, Denmark.
-
What is the size of Twelve bio?
Twelve bio has 2 total employees.
-
What industry is Twelve bio in?
Twelve bio’s primary industry is Other Healthcare Technology Systems.
-
Is Twelve bio a private or public company?
Twelve bio is a Private company.
-
What is Twelve bio’s current revenue?
The current revenue for Twelve bio is .
-
How much funding has Twelve bio raised over time?
Twelve bio has raised $7.21M.
-
Who are Twelve bio’s investors?
Arix Bioscience, BioInnovation Institute, and Novo Holdings have invested in Twelve bio.
-
When was Twelve bio acquired?
Twelve bio was acquired on 05-Jan-2023.
-
Who acquired Twelve bio?
Twelve bio was acquired by Ensoma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
